David Allen Weber
Net Worth
Last updated:
What is David Allen Weber net worth?
The estimated net worth of Dr. David Allen Weber is at least $9,358,701 as of 28 Mar 2022. He owns shares worth $41,506 as insider, has earned $46,295 from insider trading and has received compensation worth at least $9,270,900 in Otonomy, Inc..
What is the salary of David Allen Weber?
Dr. David Allen Weber salary is $927,090 per year as Pres, Chief Executive Officer & Director in Otonomy, Inc..
How old is David Allen Weber?
Dr. David Allen Weber is 65 years old, born in 1960.
What stocks does David Allen Weber currently own?
As insider, Dr. David Allen Weber owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Otonomy, Inc. (OTIC) | Pres, Chief Executive Officer & Director | 377,499 | $0.11 | $41,506 |
What does Otonomy, Inc. do?
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
David Allen Weber insider trading
Otonomy, Inc.
Dr. David Allen Weber has made 7 insider trades between 2015-2022, according to the Form 4 filled with the SEC. Most recently he sold 11,243 units of OTIC stock worth $27,129 on 28 Mar 2022.
The largest trade he's ever made was exercising 11,243 units of OTIC stock on 28 Mar 2022. As of 28 Mar 2022 he still owns at least 377,499 units of OTIC stock.
Otonomy key executives
Otonomy, Inc. executives and other stock owners filed with the SEC:
- Dr. David Allen Weber (65) Pres, Chief Executive Officer & Director
- Dr. Jay B. Lichter Ph.D. (63) Co-Founder & Independent Chairman
- Mr. Paul E. Cayer (63) Chief Financial & Bus. Officer
- Mr. Robert Michael Savel II (57) Chief Technical Officer